Anti-HIF-1alpha antibody-conjugated pluronic triblock copolymers encapsulated with Paclitaxel for tumor targeting therapy.
about
RGD-conjugated silica-coated gold nanorods on the surface of carbon nanotubes for targeted photoacoustic imaging of gastric cancer.HAI-178 antibody-conjugated fluorescent magnetic nanoparticles for targeted imaging and simultaneous therapy of gastric cancer.Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs.Current advances in polymer-based nanotheranostics for cancer treatment and diagnosisSustained release of VEGF from PLGA nanoparticles embedded thermo-sensitive hydrogel in full-thickness porcine bladder acellular matrix.Biocompatibility of Graphene Oxide.Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA.RGD Peptides-Conjugated Pluronic Triblock Copolymers Encapsulated with AP-2α Expression Plasmid for Targeting Gastric Cancer Therapy in Vitro and in Vivo.Preparation and optimization of matrix metalloproteinase-1-loaded poly(lactide-co-glycolide-co-caprolactone) nanoparticles with rotatable central composite design and response surface methodology.Copolymers: efficient carriers for intelligent nanoparticulate drug targeting and gene therapy.Polymer-based stimuli-responsive nanosystems for biomedical applications.Nanomedicine and cancer immunotherapy - targeting immunosuppressive cells.Recent progress in drug delivery of pluronic P123: pharmaceutical perspectives.Antibody-targeted nanoparticles for cancer treatment.In vivo multimodality imaging of miRNA-16 iron nanoparticle reversing drug resistance to chemotherapy in a mouse gastric cancer model.Polymeric micelles for targeted tumor therapy of platinum anticancer drugs.Tunable stimuli-responsive self-assembly system that forms and stabilizes nanoparticles by simple mixing and heating/cooling of selected block copolymersControlled Aspect Ratios of Gold Nanorods in Reduction-Limited Conditions
P2860
Q30436453-692106E9-1F71-4646-96D2-607947E72508Q33736630-DBF2ECE6-0229-4E1E-8B9A-DE35BD00DF1FQ33908184-E1F17266-5611-4B77-82B3-4F5F7568B32CQ34783018-3A9A9B05-E881-4950-8D61-54CA47B2BE78Q35536972-D65B6AC3-A0B4-4B0C-88A5-56497FBAE35CQ35538778-1039EDAF-E0D1-47AE-B04A-D5025CE8D701Q35813076-8C0DC001-07C4-400E-8D42-C821E7935C2EQ35902627-55B4F028-304E-484C-8184-78AB2EEAB740Q36278487-6460D8B0-F548-4811-81A6-F6BDD2C653F8Q37946820-C72B146D-485E-446D-AA8C-2EFB5DDA185FQ38120724-5118767B-5A69-4AEB-A649-E9E7DB00CB6AQ38603362-55427194-CBE4-416C-A1A0-F4EC913057E1Q38764283-F9DE4282-C6DB-40A2-BF26-439EFEDD7DC7Q38887307-F15224F2-6E5E-4E1F-952A-2381937FED71Q38946783-9E7576E1-6C83-494F-88F4-BBED925F3F56Q50960383-E4D7DD40-4107-4356-808E-34B49AE6272AQ57363891-CA0BC9FA-5B5A-4159-A261-2CDE42FCFFC7Q58690879-F5937635-A3D3-49F1-87C3-689025F496C1
P2860
Anti-HIF-1alpha antibody-conjugated pluronic triblock copolymers encapsulated with Paclitaxel for tumor targeting therapy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Anti-HIF-1alpha antibody-conju ...... l for tumor targeting therapy.
@ast
Anti-HIF-1alpha antibody-conju ...... l for tumor targeting therapy.
@en
Anti-HIF-1alpha antibody-conju ...... l for tumor targeting therapy.
@nl
type
label
Anti-HIF-1alpha antibody-conju ...... l for tumor targeting therapy.
@ast
Anti-HIF-1alpha antibody-conju ...... l for tumor targeting therapy.
@en
Anti-HIF-1alpha antibody-conju ...... l for tumor targeting therapy.
@nl
prefLabel
Anti-HIF-1alpha antibody-conju ...... l for tumor targeting therapy.
@ast
Anti-HIF-1alpha antibody-conju ...... l for tumor targeting therapy.
@en
Anti-HIF-1alpha antibody-conju ...... l for tumor targeting therapy.
@nl
P2093
P1433
P1476
Anti-HIF-1alpha antibody-conju ...... l for tumor targeting therapy.
@en
P2093
Chenchen Bao
Daxiang Cui
P304
P356
10.1016/J.BIOMATERIALS.2009.11.067
P577
2009-12-11T00:00:00Z